Initial Outcomes No Worse for Surgical ICU Patients With CA

Share this content:
Initial Outcomes No Worse for Surgical ICU Patients With CA
Initial Outcomes No Worse for Surgical ICU Patients With CA

FRIDAY, June 29, 2018 (HealthDay News) -- Surgical patients who are admitted to the intensive care unit (ICU) and have cancer do not have worse initial outcomes than those without cancer, according to a study published online June 27 in JAMA Surgery.

Kathryn Puxty, M.B.Ch.B., M.D., from Glasgow Royal Infirmary in the United Kingdom, and colleagues conducted an observational retrospective cohort study using ICU audit records linked to hospitalization discharge summaries, cancer registrations, and death records of 16 ICUs. Data were included for 25,017 surgical ICU admissions between Jan. 1, 2000, and Dec. 31, 2011.

The researchers found that 21.8 percent of the surgical ICU patients had an underlying solid tumor diagnosis. The cancer group had lower ICU and hospital mortality than the noncancer group, at 12.2 versus 16.8 percent and 22.9 versus 28.1 percent (both P < 0.001). The adjusted odds ratio for hospital mortality was 1.09 (95 percent confidence interval, 1 to 1.19) for patients with cancer. By six months, mortality was higher in the cancer versus the noncancer group (31.3 versus 28.2 percent; P < 0.001). For those with and without cancer, mortality was 60.9 versus 39.7 percent four years after ICU admission (P < 0.001).

"Cancer is a common diagnosis among surgical ICU patients and this study suggests that initial outcomes compare favorably with those of ICU patients with other conditions," the authors write. "Consideration that a diagnosis of cancer should not preclude admission to the ICU in patients with surgical disease is suggested."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »